Aberrant methylation of N-methyl-D-aspartate receptor type 2B (NMDAR2B) in non-small cell carcinoma.
about
Genetic variants at 6p21.1 and 7p15.3 are associated with risk of multiple cancers in Han ChineseToward an epigenetic view of our musical mind.Glutamate and its receptors in cancerHypoxia-inducible factors enhance glutamate signaling in cancer cellsComprehensive genomic characterization of cutaneous malignant melanoma cell lines derived from metastatic lesions by whole-exome sequencing and SNP array profilingExclusive Association of p53 Mutation with Super-High Methylation of Tumor Suppressor Genes in the p53 Pathway in a Unique Gastric Cancer Phenotype.Molecular pathways: dysregulated glutamatergic signaling pathways in cancerAberrant methylation of LINE-1, SLIT2, MAL and IGFBP7 in non-small cell lung cancer.The Markers of Glutamate Metabolism in Peripheral Blood Mononuclear Cells and Neurological Complications in Lung Cancer Patients.NMDA receptors on the surface of cancer cells: target for chemotherapy?A systems medicine approach for finding target proteins affecting treatment outcomes in patients with non-Hodgkin lymphoma.Analysis of bladder cancer tumor CpG methylation and gene expression within The Cancer Genome Atlas identifies GRIA1 as a prognostic biomarker for basal-like bladder cancer.[The cancer paradigm in pulmonary arterial hypertension: towards anti-remodeling therapies targeting metabolic dysfunction?]
P2860
Q28943390-D1B33254-64A5-4761-AC2A-1D98B3262DACQ30412523-C6B71CBB-9852-4D8A-8F57-2C94E45E9A86Q34048497-B800331A-9F29-4E80-9722-21D6BD4727F2Q34619124-89087B1D-E717-4223-84D6-DA4724174B6BQ34737562-F70EF43B-AEC2-49F3-9B28-E2F782D202C2Q36136842-1D26F56B-75FA-42BE-84B0-BAE7F67B3E35Q36170150-3EE2042C-B0E4-4126-A86A-3CBC382692D3Q36753304-567192A6-B672-45B4-8272-58F7E207F1E7Q37511897-B5B0FB1F-49C4-4D65-A54C-08CBDF461DC9Q38205972-A7C25D7C-5510-4695-AA73-C1CB48A856C3Q41367937-BF3523EF-C075-4A71-A4E2-8C3E97FE7AC3Q42367899-80E28CB3-2BF3-49F7-B3B3-7178226F2CFBQ52312423-5F54C569-B465-4CFE-B409-3BDDD4B3B2A5
P2860
Aberrant methylation of N-methyl-D-aspartate receptor type 2B (NMDAR2B) in non-small cell carcinoma.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Aberrant methylation of N-meth ...... ) in non-small cell carcinoma.
@ast
Aberrant methylation of N-meth ...... ) in non-small cell carcinoma.
@en
type
label
Aberrant methylation of N-meth ...... ) in non-small cell carcinoma.
@ast
Aberrant methylation of N-meth ...... ) in non-small cell carcinoma.
@en
prefLabel
Aberrant methylation of N-meth ...... ) in non-small cell carcinoma.
@ast
Aberrant methylation of N-meth ...... ) in non-small cell carcinoma.
@en
P2093
P2860
P356
P1433
P1476
Aberrant methylation of N-meth ...... ) in non-small cell carcinoma.
@en
P2093
Hajime Tamura
Hidehisa Hoshino
Ichiro Yoshino
Makoto Suzuki
Shigetoshi Yoshida
Tatsuro Okamoto
Yasumitsu Moriya
P2860
P2888
P356
10.1186/1471-2407-11-220
P407
P577
2011-06-05T00:00:00Z
P5875
P6179
1016063472